Shingrix Injection, Solution
Product Images NDC 58160-849

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Shingrix (NDC 58160-849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Shingrix-spl-graphic-01 (Shingrix Spl Graphic 01)

This text provides a list of words - Adjuvant, Suspension, and Component - followed by the description "liquid". It appears to be a partial list of components for a product or formula.*

FDA Label Image

Shingrix-spl-graphic-02 (Shingrix Spl Graphic 02)

This is a description of a lyophilized (freeze-dried) powder form of an antigen component called gE. No further information is provided.*

FDA Label Image

Shingrix-spl-graphic-03 (Shingrix Spl Graphic 03)

FDA Label Image

Shingrix-spl-graphic-04 (Shingrix Spl Graphic 04)

FDA Label Image

Shingrix 1 Count Carton (Shingrix Spl Graphic 05)

This text is a description of a vaccine called SHINGRIX with NDC number 58160-819-12. It contains a lyophilized powder and a liquid suspension which should be combined before use. The vaccine is for individuals who are 50 years or older and those who are immunocompromised and at an increased risk of herpes zoster. The vaccine contains a g lyophilized gE antigen component and a g adjuvant suspension component with a single dose of 0.5 mL after reconstitution.*

FDA Label Image

Shingrix 1 Count Adjuvant Vial Label (Shingrix Spl Graphic 06)

This appears to be a product label for a pharmaceutical product called SHINGRIX H. The label contains important information for medical practitioners or patients about the product's components, administration, and advice on its use. The product is manufactured by GlaxoSmithKline Biologicals.*

FDA Label Image

Shingirx 1 Count Antigen Vial Label (Shingrix Spl Graphic 07)

This is a pharmaceutical product for SHINGRIX E. It contains lyophilized gE antigen component and should not be used alone. It needs to be reconstituted with the adjuvant suspension component to form a single dose of 0.5mL after reconstitution. The manufacturer is GlaxoSmithKline Biologicals. The lot number is SEBI6Y and the expiration date is not available. The product has an NDC code of 58160-828-01.*

FDA Label Image

Shingrix 10 Count Carton (Shingrix Spl Graphic 08)

This is a prescription drug with NDC number 58160-823-11. It is a recombinant, adjuvanted Zoster vaccine named SHINGRIX. The drug is supplied as one vial of lyophilized powder and one vial of liquid suspension, which must be combined before use to produce a single 0.5 mL dose. It is indicated for individuals of 50 years of age or older who are immunocompromised and at high risk of Herpes Zoster. The package contains ten doses of SHINGRIX.*

FDA Label Image

Shingrix 10 Count Adjuvant Vial Label (Shingrix Spl Graphic 09)

This is a product label for one of the components required to create the SHINGRIX vaccine. It includes information on dosage, usage and manufacturer details.*

FDA Label Image

Shingrix 10 Count Antigen Vial Label (Shingrix Spl Graphic 10)

This is a product description for a vaccine called SHINGRIX. It has an NDC number of 58160-828-03, and comes in a two-part vial. The first vial contains lyophilized gE antigen component, which should not be used alone. The second vial contains an adjuvant suspension component to be used to reconstitute the antigen component. After reconstitution, the product creates a 0.5mL single-dose vaccine. It is manufactured by GlaxoSmithKline Biologicals. The remaining text is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.